Obsessive-Compulsive Disorder Global Market Report 2025

Description

Obsessive-compulsive disorder (OCD) is a mental health condition characterized by persistent, intrusive thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) performed to alleviate anxiety. These behaviors often disrupt daily functioning and cause significant emotional distress. Common themes include concerns about cleanliness, orderliness, and fear of harm. Treatment generally involves a combination of therapy and medication.

The primary drug classes for OCD treatment include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), serotonin antagonist and reuptake inhibitors (SARIs), and tricyclic antidepressants (TCAs). SSRIs, a commonly prescribed class, function by increasing serotonin levels in the brain and preventing its reabsorption into nerve cells. These medications are also indicated for other conditions such as major depressive disorder, anxiety disorders, and attention deficit hyperactivity disorder (ADHD). The distribution channels for these drugs include hospital pharmacies, retail pharmacies, and other outlets, serving end users such as hospitals, specialty clinics, and other healthcare facilities.

The obsessive-compulsive disorder market research report is one of a series of new reports from The Business Research Company that provides obsessive-compulsive disorder market statistics, including obsessive-compulsive disorder industry global market size, regional shares, competitors with a obsessive-compulsive disorder market share, detailed obsessive-compulsive disorder market segments, market trends and opportunities, and any further data you may need to thrive in the obsessive-compulsive disorder industry. This obsessive-compulsive disorder market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The obsessive-compulsive disorder market size has grown strongly in recent years. It will grow from $0.62 billion in 2024 to $0.67 billion in 2025 at a compound annual growth rate (CAGR) of 8.64%. The growth during the historic period was driven by factors such as an increase in early diagnosis, a rising prevalence of mental health conditions, the expanded use of cognitive behavioral therapy (CBT), improved access to online therapy, and the development of personalized treatment plans.

The obsessive-compulsive disorder market size is expected to see strong growth in the next few years. It will grow to $0.93 billion in 2029 at a compound annual growth rate (CAGR) of 8.38%. In the forecast period, growth is expected to be propelled by a rising prevalence of OCD, increasing demand for off-label drugs and therapies, heightened investment in the healthcare sector, growing awareness campaigns, and enhanced government initiatives. Key trends anticipated during this period include advancements in technology, the integration of digital health tools, the use of virtual reality in treatment, the expansion of telehealth services, and the continued adoption of cognitive behavioral therapy.

The increasing prevalence of mental illness is projected to drive growth in the obsessive-compulsive disorder (OCD) market. Mental illnesses encompass a broad spectrum of conditions that impact mood, thinking, behavior, and overall functioning. Their rise is attributed to greater awareness and diagnosis, lifestyle shifts, chronic stress, global crises, and escalating social, economic, and environmental pressures. OCD serves as a focal point for understanding the complexities of mental illnesses, advancing research, diagnosis, and treatment methods for various mental health conditions. For example, in September 2024, the National Institutes of Health (NIH) reported that in 2022, 59.3 million U.S. adults (23.1% of the population) experienced AMI (Any Mental Illness), with a higher prevalence among females (26.4%) compared to males (19.7%). This growing prevalence highlights the expanding demand for OCD-related treatments, boosting the market's growth.

Companies in the OCD market are innovating mental health treatment to deliver more effective therapeutic options. These treatments include a range of therapies, medications, and lifestyle interventions aimed at managing and alleviating mental health conditions. In October 2023, Newport Healthcare introduced a specialized OCD Treatment Program for teens and young adults. This initiative addresses the developmental and psychological needs of younger individuals with OCD and related disorders. By employing evidence-based therapies such as Cognitive Behavioral Therapy (CBT), Exposure and Response Prevention (ERP), and family-centered approaches, the program ensures accessible, holistic care. It integrates mental health treatment with mindfulness practices, physical wellness, and life skills training to promote comprehensive recovery.

In August 2023, Talkiatry partnered with NOCD to revolutionize OCD treatment through integrated services. This collaboration aims to enhance patient outcomes by combining NOCD's specialized ERP therapy with Talkiatry's psychiatric care expertise. NOCD, a U.S.-based mental health technology company, specializes in online therapy for OCD, making this partnership a strategic move to improve accessibility and streamline OCD care.

Major players in the obsessive-compulsive disorder market are Pfizer Inc., Merck & Co. Inc., Abbott Laboratories, Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Zydus Cadila, Amneal Pharmaceuticals Inc., Mallinckrodt plc, Lupin Pharmaceuticals Inc., Par Pharmaceutical, Biohaven Pharmaceuticals.

North America was the largest region in the obsessive-compulsive disorder market in 2024. The regions covered in obsessive-compulsive disorder report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the obsessive-compulsive disorder market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The obsessive-compulsive disorder market includes revenues earned by entities by providing services such as diagnosing, treating, and managing mental health conditions and related products including benzodiazepines, neurostimulation devices, and ERP therapy tools. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Obsessive-Compulsive Disorder Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on obsessive-compulsive disorder market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for obsessive-compulsive disorder ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The obsessive-compulsive disorder market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Selective Serotonin Reuptake Inhibitors; Serotonin-Norepinephrine Reuptake Inhibitors; Monoamine Oxidase Inhibitors; Serotonin Antagonist And Reuptake Inhibitors; Tricyclic Obsessive Compulsive Disorder
2) By Indication: Major Depressive Disorder; Anxiety Disorders; Attention Deficit Hyperactivity Disorder
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channels
4) By End-Users: Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By Selective Serotonin Reuptake Inhibitors (SSRIs): Fluoxetine; Sertraline; Paroxetine; Escitalopram
2) By Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Duloxetine; Venlafaxine
3) By Monoamine Oxidase Inhibitors (MAOIs): Moclobemide; Phenelzine
4) By Serotonin Antagonist And Reuptake Inhibitors (SARI): Trazodone; Nefazodone
5) By Tricyclic Obsessive Compulsive Disorder: Clomipramine; Amitriptyline
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Abbott Laboratories; Novartis AG; Eli Lilly and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33837

1. Executive Summary

2. Obsessive-Compulsive Disorder Market Characteristics

3. Obsessive-Compulsive Disorder Market Trends And Strategies

4. Obsessive-Compulsive Disorder Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Obsessive-Compulsive Disorder Growth Analysis And Strategic Analysis Framework

5.1. Global Obsessive-Compulsive Disorder PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Obsessive-Compulsive Disorder Market Growth Rate Analysis
5.4. Global Obsessive-Compulsive Disorder Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Obsessive-Compulsive Disorder Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Obsessive-Compulsive Disorder Total Addressable Market (TAM)

6. Obsessive-Compulsive Disorder Market Segmentation

6.1. Global Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist And Reuptake Inhibitors
Tricyclic Obsessive Compulsive Disorder
6.2. Global Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Major Depressive Disorder
Anxiety Disorders
Attention Deficit Hyperactivity Disorder
6.3. Global Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Other Distribution Channels
6.4. Global Obsessive-Compulsive Disorder Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Other End-Users
6.5. Global Obsessive-Compulsive Disorder Market, Sub-Segmentation Of Selective Serotonin Reuptake Inhibitors (SSRIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluoxetine
Sertraline
Paroxetine
Escitalopram
6.6. Global Obsessive-Compulsive Disorder Market, Sub-Segmentation Of Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Duloxetine
Venlafaxine
6.7. Global Obsessive-Compulsive Disorder Market, Sub-Segmentation Of Monoamine Oxidase Inhibitors (MAOIs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Moclobemide
Phenelzine
6.8. Global Obsessive-Compulsive Disorder Market, Sub-Segmentation Of Serotonin Antagonist And Reuptake Inhibitors (SARI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Trazodone
Nefazodone
6.9. Global Obsessive-Compulsive Disorder Market, Sub-Segmentation Of Tricyclic Obsessive Compulsive Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clomipramine
Amitriptyline

7. Obsessive-Compulsive Disorder Market Regional And Country Analysis

7.1. Global Obsessive-Compulsive Disorder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Obsessive-Compulsive Disorder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Obsessive-Compulsive Disorder Market

8.1. Asia-Pacific Obsessive-Compulsive Disorder Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Obsessive-Compulsive Disorder Market

9.1. China Obsessive-Compulsive Disorder Market Overview
9.2. China Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Obsessive-Compulsive Disorder Market

10.1. India Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Obsessive-Compulsive Disorder Market

11.1. Japan Obsessive-Compulsive Disorder Market Overview
11.2. Japan Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Obsessive-Compulsive Disorder Market

12.1. Australia Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Obsessive-Compulsive Disorder Market

13.1. Indonesia Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Obsessive-Compulsive Disorder Market

14.1. South Korea Obsessive-Compulsive Disorder Market Overview
14.2. South Korea Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Obsessive-Compulsive Disorder Market

15.1. Western Europe Obsessive-Compulsive Disorder Market Overview
15.2. Western Europe Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Obsessive-Compulsive Disorder Market

16.1. UK Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Obsessive-Compulsive Disorder Market

17.1. Germany Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Obsessive-Compulsive Disorder Market

18.1. France Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Obsessive-Compulsive Disorder Market

19.1. Italy Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Obsessive-Compulsive Disorder Market

20.1. Spain Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Obsessive-Compulsive Disorder Market

21.1. Eastern Europe Obsessive-Compulsive Disorder Market Overview
21.2. Eastern Europe Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Obsessive-Compulsive Disorder Market

22.1. Russia Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Obsessive-Compulsive Disorder Market

23.1. North America Obsessive-Compulsive Disorder Market Overview
23.2. North America Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Obsessive-Compulsive Disorder Market

24.1. USA Obsessive-Compulsive Disorder Market Overview
24.2. USA Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Obsessive-Compulsive Disorder Market

25.1. Canada Obsessive-Compulsive Disorder Market Overview
25.2. Canada Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Obsessive-Compulsive Disorder Market

26.1. South America Obsessive-Compulsive Disorder Market Overview
26.2. South America Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Obsessive-Compulsive Disorder Market

27.1. Brazil Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Obsessive-Compulsive Disorder Market

28.1. Middle East Obsessive-Compulsive Disorder Market Overview
28.2. Middle East Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Obsessive-Compulsive Disorder Market

29.1. Africa Obsessive-Compulsive Disorder Market Overview
29.2. Africa Obsessive-Compulsive Disorder Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Obsessive-Compulsive Disorder Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Obsessive-Compulsive Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Obsessive-Compulsive Disorder Market Competitive Landscape And Company Profiles

30.1. Obsessive-Compulsive Disorder Market Competitive Landscape
30.2. Obsessive-Compulsive Disorder Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Obsessive-Compulsive Disorder Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Ltd.
31.2. Boehringer Ingelheim International GmbH
31.3. Otsuka Pharmaceutical Co. Ltd.
31.4. Astellas Pharma Inc.
31.5. Daiichi Sankyo Company Limited
31.6. Hetero Labs Limited
31.7. Sun Pharmaceutical Industries Ltd.
31.8. Cipla Limited
31.9. Hikma Pharmaceuticals PLC
31.10. Dr. Reddy's Laboratories Ltd.
31.11. Aurobindo Pharma Limited
31.12. Zydus Cadila
31.13. Amneal Pharmaceuticals Inc.
31.14. Mallinckrodt plc
31.15. Lupin Pharmaceuticals Inc.

32. Global Obsessive-Compulsive Disorder Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Obsessive-Compulsive Disorder Market

34. Recent Developments In The Obsessive-Compulsive Disorder Market

35. Obsessive-Compulsive Disorder Market High Potential Countries, Segments and Strategies

35.1 Obsessive-Compulsive Disorder Market In 2029 - Countries Offering Most New Opportunities
35.2 Obsessive-Compulsive Disorder Market In 2029 - Segments Offering Most New Opportunities
35.3 Obsessive-Compulsive Disorder Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer